ArticleCureus2026
Patient-Provider Discussions on Lung Cancer Screening: Insights From the Health Information National Trends Survey (HINTS).
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Lung cancer risk is significantly elevated in individuals with chronic lung diseases (CLDs), including asthma, emphysema, and chronic bronchitis. Despite this, lung cancer screening (LCS) remains underutilized in this high-risk population. This study aimed to examine the factors associated with patient-provider discussions about LCS among adults with CLD. Methodology Using data from four cycles of the Health Information National Trends Survey (HINTS) from 2013 to 2022, we examined patient-provider communication patterns about LCS among respondents over the age of 50 years with a smoking history and CLD. Results Of the 828 eligible respondents, only 26.3% reported having discussed LCS with a healthcare provider. Older age, non-Hispanic ethnicity, and prior discussions about colorectal cancer screening were associated with higher rates of LCS conversations, while food insecurity significantly decreased the likelihood of such discussions. Notably, conversations peaked in 2020 but declined sharply by 2022, potentially reflecting disruptions in preventive care due to the COVID-19 pandemic. Conclusions Our findings highlight the persistent communication gap around LCS in CLD patients, emphasizing the need for improved provider engagement and awareness. Socioeconomic disparities and limited preventive care access continue to influence screening uptake. Interventions that promote shared decision-making, address social determinants of health, and integrate LCS discussions into routine care could enhance early detection and reduce lung cancer-related morbidity and mortality in this vulnerable population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.